Orexo AB
OTC:ORXOF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Orexo AB
OTC:ORXOF
|
SE |
|
G
|
Greatland Gold PLC
OTC:GRLGF
|
UK |
|
HEICO Corp
NYSE:HEI
|
US |
|
B
|
Bloomberry Resorts Corp
XPHS:BLOOM
|
PH |
|
L
|
Lumentum Holdings Inc
SWB:LU2
|
US |
|
A
|
Avista Corp
F:AV6
|
US |
|
S
|
Saipem SpA
F:SPEA
|
IT |
|
Jackpot Digital Inc
XTSX:JJ
|
CA |
|
K
|
KDDI Corp
DUS:DIP
|
JP |
|
T
|
Taiwan Advance Bio-Pharmaceutical Inc
TPEX:4186
|
TW |
|
8
|
8x8 Inc
F:EGT
|
US |
|
N
|
Nokia Oyj
F:NOAA
|
FI |
|
J
|
J.M. Smucker Co
F:JM2
|
US |
|
Bathurst Resources Ltd
ASX:BRL
|
NZ |
|
Singapore Post Ltd
OTC:SPSTY
|
SG |
|
S
|
SoftBank Group Corp
F:SFT
|
JP |
|
V
|
Volkswagen AG
PSE:VOW
|
DE |
|
A
|
Applied Materials Inc
XMUN:AP2
|
US |
Bankruptcy Probability
Orexo AB's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Orexo AB Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SE |
|
Orexo AB
STO:ORX
|
48.2m SEK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.3T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
655.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
OTC:RHHBF
|
391.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
362.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
253.3B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
217.8B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.2T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
167.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
129B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Sanofi SA
PAR:SAN
|
100.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Orexo AB's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Orexo AB has total debt of 2.8m SEK. This includes both short-term (0 SEK) and long-term (2.8m SEK) debt.
You can find a full breakdown on its Balance Sheet.
